Selling, General and Administrative Expense - Schedule of Selling, General and Administrative Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Non-cash expenses: | ||
| Bad debt provision | $ 55 | $ 4 |
| Stock based compensation | 1,049 | 1,289 |
| Total SG&A expense | 10,771 | 17,336 |
| Selling, General and Administrative Expenses | ||
| Cash expenses: | ||
| Compensation and benefits | 3,969 | 9,230 |
| Professional services | 3,538 | 3,789 |
| Other | 2,309 | 3,244 |
| Total cash SG&A expense | 9,816 | 16,263 |
| Non-cash expenses: | ||
| Bad debt provision | 55 | 4 |
| Stock based compensation | 900 | 1,069 |
| Total non-cash SG&A expense | 955 | 1,073 |
| Total SG&A expense | $ 10,771 | $ 17,336 |
| X | ||||||||||
- Definition Selling General And Administrative Expense, Cash Portion [Abstract] No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Cash Portion No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Including Related and Third Parties No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Non Cash Portion No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Non Cash Portion [Abstract] No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|